Symmetry Medical (NYSE:SMA) shares are up about 4 percent today to $9.01 each in mid-session trading, despite reporting fourth-quarter earnings below analysts’ expectations last night
That may be due to the Warsaw, Ind.-based orthopedic company’s forecast of 6 percent top-line growth. Revenues could reach as high as $383 million this year, up from $360.8 million in 2010 and just shy of the Wall Street call.
The company also forecast earnings of 57 cents to 65 cents a share, below the average 69 cent EPS predicted by analyst in a Thomson Reuters poll.
Fourth-quarter net income was $4.3 million, or 12 cents per share, with revenues climbing 26 percent over year-ago levels to $96 million. Excluding certain one-time items, adjusted EPS was 14 cents — still under the 15-cent-per-share analysts were expecting.
The analyst consensus currently calls for full-year EPS to be 69 cents.